Laboratory Analytical Instruments - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Laboratory industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Laboratory Analytical Instruments - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Laboratory Analytical Instruments
Corporate Insider Buy Sell Ratio (Insider Count) - Laboratory Analytical Instruments
Laboratory Analytical Instruments - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2026-06-03 BNGO / Bionano Genomics, Inc. 4 Chaubey Alka F - Taxes D 1.3 -24
2026-06-03 A / Agilent Technologies, Inc. 4 MCDONNELL PADRAIG F - Taxes D 137.40 -418
2026-06-03 BNGO / Bionano Genomics, Inc. 4 Dixon Jonathan V. F - Taxes D 1.3 -24
2026-06-03 BNGO / Bionano Genomics, Inc. 4 Borodkin Mark F - Taxes D 1.3 -27
2026-06-03 BNGO / Bionano Genomics, Inc. 4 Adamchak Mark F - Taxes D 1.3 -7
2026-06-02 ILMN / Illumina, Inc. 4 Leckman Patricia S - Sale D 163.02 -290
2026-06-02 NAUT / Nautilus Biotechnology, Inc. 4 AH Equity Partners Bio II, L.L.C. By AH Bio Fund II, L.P. S - Sale I 2.35 -4,615,974
2026-06-02 ILMN / Illumina, Inc. 4 Leckman Patricia S - Sale D 162.00 -318
2026-06-02 NAUT / Nautilus Biotechnology, Inc. 4 AH Equity Partners Bio II, L.L.C. By Andreessen Horowitz LSV Fund II, L.P. S - Sale I 2.35 -384,026
2026-06-02 ILMN / Illumina, Inc. 4 Leckman Patricia S - Sale D 160.66 -176
2026-06-01 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 163.56 -61,613
2026-06-01 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 162.41 -70,262
2026-06-01 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 165.5 -15,472
2026-06-01 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 164.34 -87,653
2026-05-31 QTRX / Quanterix Corporation 4 Miller Michael Francis M - Exercise D 130
2026-05-31 QTRX / Quanterix Corporation 4 Miller Michael Francis F - Taxes D 3.06 -39
2026-05-29 A / Agilent Technologies, Inc. 4 Dolsten Mikael S - Sale D 135.42 -1,600
2026-05-29 ILMN / Illumina, Inc. 4 Ericksen Scott D S - Sale D 160.00 -500
2026-05-29 ILMN / Illumina, Inc. 4 Davies Scott M S - Sale D 160.00 -615
2026-05-29 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 162.86 -63,020
2026-05-29 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 161.64 -5,256
2026-05-29 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 165.3 -1,961
2026-05-29 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 159.57 -11,760
2026-05-29 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 163.57 -19,832
2026-05-29 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 164.75 -6,888
2026-05-29 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 160.5 -4,579
2026-05-29 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 163.97 -6,198
2026-05-29 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 164.56 -92,877
2026-05-29 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 162.44 -2,225
2026-05-29 RPID / Rapid Micro Biosystems, Inc. 4 PEI MELINDA LITHERLAND A - Award D 1.955 12,787
2026-05-29 RPID / Rapid Micro Biosystems, Inc. 4 WIRTJES SEAN M A - Award D 1.955 12,787
2026-05-29 RPID / Rapid Micro Biosystems, Inc. 4 Spignesi Robert G. Jr. A - Award D 1.955 12,787
2026-05-29 RPID / Rapid Micro Biosystems, Inc. 4 LOWENSTEIN INESE A - Award D 1.955 12,787
2026-05-29 RPID / Rapid Micro Biosystems, Inc. 4 Malloy Kirk A - Award D 1.955 12,787
2026-05-28 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes X - Other I 102.82 24,562
2026-05-28 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 147.5 -110,424
2026-05-28 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 157.38 -71,986
2026-05-28 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes S - Sale I 156.5 -37,590
2026-05-28 ILMN / Illumina, Inc. 4 Ericksen Scott D S - Sale D 150.10 -1,500
2026-05-28 ILMN / Illumina, Inc. 4 Meister Keith A. See Footnotes J - Other I 156.4 -24,562
2026-05-26 TXG / 10x Genomics, Inc. 4 Saxonov Serge S - Sale D 24.7092 -10,718
2026-05-25 EYPT / EyePoint, Inc. 4 Elston George M - Exercise D 7,500
2026-05-25 EYPT / EyePoint, Inc. 4 Elston George F - Taxes D 12.93 -3,627
2026-05-22 TXG / 10x Genomics, Inc. 4 Hindson Benjamin J. S - Sale D 24.4415 -11,595
2026-05-22 TXG / 10x Genomics, Inc. 4 Saxonov Serge S - Sale D 24.4415 -18,175
2026-05-22 TXG / 10x Genomics, Inc. 4 Taich Adam S - Sale D 24.4415 -15,098
2026-05-21 PRPO / Precipio, Inc. 4 SANDBERG RICHARD A Wythburn Associates, Ltd, 94% owned jointly by reporting person and spouse S - Sale I 25.0193 -900
2026-05-21 ILMN / Illumina, Inc. 4 Meister Keith A. A - Award D 144.83 2,072
2026-05-21 RPID / Rapid Micro Biosystems, Inc. 4 Malloy Kirk A - Award D 19,300
2026-05-21 ILMN / Illumina, Inc. 4 SCHILLER PHILIP W A - Award D 144.83 2,072
P
Acquisto sul mercato aperto o privato di un titolo non derivato o derivato
S
Vendita sul mercato aperto o privato di un titolo non derivato o derivato
A
Concessione, assegnazione o altra acquisizione di titoli dall'azienda (ad esempio un'opzione)
C
Conversione di un derivato
D
Vendita o trasferimento di titoli alla società
F
Pagamento del prezzo di esercizio o del debito fiscale con la quota di titoli ricevuta dalla società
G
Regalo di titoli da parte o a favore dell'insider
K
Equity swap e operazioni di copertura analoghe
M
Esercizio o conversione di un titolo derivato ricevuto dall'azienda (ad esempio un'opzione)
V
Una transazione dichiarata volontariamente sul modulo 4
J
Altro (accompagnato da una nota a piè di pagina che descriva l'operazione)